2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs 

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2669
  



  

  
Submitter : 
  

  
Dr. Thomas Fine
  

  
Date & Time: 
  

  
02/16/2006 12:02:19
  



  

  
Organization : 
  

  
MBNA
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I am writing to encourage lawmakers and the FDA to resist pressure from certain groups in the pharmaceutical industry who are attemping to limit free trade and to proscribe public health by establishing laws blocking the use of bio-identical hormones that are administered under the care of phyicians and compounded by responsible pharmacies.  This lobbying effort is clearly an administrative ploy to establish favorable market conditions for companies selling artificial hormones by eliminating the competition.